Tazemetostat, (Tazedx) works for treating Adults and pediatric patients (16+) with metastatic or locally advanced epithelioid sarcoma ineligible for complete resection. Adults with relapsed or refractory follicular lymphoma (R/R FL) with EZH2 mutations after at least two prior systemic therapies or without satisfactory alternative treatment options. Tazemetostat a is doctor prescription (Tazemetostat) medicine.
Bigbear Pharmaceutical Co. Ltd. in Laos mfg Tazedx.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tazedx tablet may be taken with or without food, but it is better to take it at a fixed time.
Suggestions:
Genuine medicine is important for treatment. So, always try to source genuine medicines from authentic sources and check the quality of medicines.
Side Effects:
The most common side effects of Tazemetostat are:
Muscle/joint/abdominal pain, tiredness, constipation, diarrhea, headache, nausea, vomiting, or loss of appetite. Tell your doctor or pharmacist right away if any of these side effects persist or worsen.
Remember that your doctor has prescribed this medication because your doctor has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
Tell your doctor right away if you have any serious side effects, including: easy bruising/bleeding.
This medication may lower your ability to fight infections. This may make you more likely to get a serious (rarely fatal) infection or make any infection you have worse. Tell your doctor right away if you have any signs of infection (such as sore throat that doesn’t go away, fever, chills, cough).
Take this medication regularly to get the most benefit from it. To help you remember, take it at the same times on the days your doctor directs.
This is not a complete list of possible side effects. Contact your doctor or pharmacist if you have any other side effects not listed above.
Reviews
There are no reviews yet.